MedPath

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Phase 3
Completed
Conditions
Hyperlipemia
Interventions
Drug: Placebo
Registration Number
NCT04781114
Lead Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Brief Summary

JS002 is a recombinant humanized anti-PCSK9 monoclonal antibody. This is a randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy, as well as immunogenicity of JS002 treated repeatedly in patients with hyperlipidemia when combined with statin therapy.

In this study, two dose group (150 mg, 300 mg) were set up in this study. 750 subjects are plan to be enrolled (the study drug will be assigned to a 2:1 ratio of JS002 or placebo).

Each subject required a maximum of 6 weeks of screening, 52 weeks of treatment, and 8 weeks of follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
806
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
JS002JS002Cohort 1: 150 mg/1mL Q2W Subcutaneous(SC); Cohort 2: 300/2mL mg Q4W Subcutaneous(SC);
PlaceboPlaceboCohort 1: 1mL Q2W Subcutaneous(SC); Cohort 2: 2mL Q4W Subcutaneous(SC);
Primary Outcome Measures
NameTimeMethod
Change in LDL-C of JS002Up to 24Weeks after dose administration

Percentage change in LDL-C relative to baseline at Week 24

Secondary Outcome Measures
NameTimeMethod
Change in LDL-C of JS002Up to 52Weeks after dose administration

Percentage change in LDL-C relative to baseline at Week 52

The occurrence of adverse eventsUp 60Weeks after dose administration

Evaluate the change of clinically significant laboratory tests, vital signs, and electrocardiogram

The immunogenicity of JS002Up 60Weeks after dose administration

To evaluate the production time, duration and proportion of anti JS002 antibody (ADA).ADA positive samples are tested for titer and for neutralizing antibody (Nab).

Pharmacokinetics (PD) of JS002Up 60Weeks after dose administration

Evaluation of serum concentrations of free/total PCSK9 and changes from baseline.Descriptive statistics include mean (arithmetic mean and geometric mean), standard deviation (SD), coefficient of variation CV% (arithmetic coefficient and geometric coefficient of variation), Median (Median), minimum (Min) and maximum (Max).

Other lipid parameters of JS002Up to Week 24 and 52Weeks after dose administration

Percentage change in LDL-C relative to baseline at Week 24 and Week 52

Pharmacokinetics (PK) of JS002Up 60Weeks after dose administration

Evaluation of Serum concentration of JS002.Descriptive statistics include mean (arithmetic mean and geometric mean), standard deviation (SD), coefficient of variation CV% (arithmetic coefficient and geometric coefficient of variation), Median (Median), minimum (Min) and maximum (Max).

Trial Locations

Locations (57)

The Second Affiliated Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

Hainan General Hospital

🇨🇳

Haikou, Hainan, China

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

The First Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

The 900 Hospital of the Joint Service Support Force of the People's Liberation Army of China

🇨🇳

Fuzhou, Fujian, China

The First Hospital of Lanzhou University City:Lanzhou

🇨🇳

Lanzhou, Gansu, China

The People's Hospital of Guangxi Zhuang Autonomous Region

🇨🇳

Nanning, Guangxi, China

Beijing Chaoyang Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

The First Affiliated Hospital of Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

Daqingshi People's Hospital

🇨🇳

Daqing, Heilongjiang, China

The First Hospital of Nanchang

🇨🇳

Nanchang, Jiangxi, China

Beijing Tongren Hospital Affiliated to Capital Medical University City:Beijing

🇨🇳

Beijing, Beijing, China

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

Northern Jiangsu People's Hospital

🇨🇳

Yangzhou, Jiangsu, China

The Second Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, Jiangxi, China

Jingzhou Central Hospital

🇨🇳

Jingzhou, Hubei, China

The First Affiliated Hospital of Jinzhou Medical University

🇨🇳

Jinzhou, Liaoning, China

Jinan Central Hospital

🇨🇳

Jinan, Shandong, China

Teda International Cardiovascular Hospital

🇨🇳

Tianjin, Tianjin, China

Shanghai East Hospital

🇨🇳

Shanghai, Shanghai, China

The First Affiliated Hospital of Bengbu Medical College

🇨🇳

Bengbu, Anhui, China

Lanzhou University Second Hospital

🇨🇳

Lanzhou, Gansu, China

Peking University Shenzhen Hospital

🇨🇳

Shenzhen, Guangdong, China

Affiliated Hospital of Guizhou Medical University

🇨🇳

Guiyang, Guizhou, China

The Second Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

The Fourth Affiliated Hospital of Harbin Medical University

🇨🇳

Haerbin, Heilongjiang, China

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

The Second People's Hospital of Changzhou

🇨🇳

Changzhou, Jiangsu, China

The Third Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

The Second Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

First Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

China-Japan Union Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

The central hospital of Dalian

🇨🇳

Dalian, Liaoning, China

The People's Hospital of Liaoning Provincial

🇨🇳

Shenyang, Liaoning, China

General Hospital of the PLA Northern Theater Command

🇨🇳

Shenyang, Liaoning, China

The Second Affiliated Hospital of Xi'an Jiaotong University

🇨🇳

Xian, Shanxi, China

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Shanghai Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

Xianyang Hospital of Yan 'an University

🇨🇳

Xianyang, Shanxi, China

The First Affiliated Hospital of the Air Force Medical University

🇨🇳

Xian, Shanxi, China

West China Hospital of Sichuan University

🇨🇳

Chengdu, Sichuan, China

Tianjin First Central Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin People's Hospital

🇨🇳

Tianjin, Tianjin, China

Taizhou Hospital of Zhejiang Province

🇨🇳

Taizhou, Zhejiang, China

The First Affiliated Hospital of Wenzhou Medical University

🇨🇳

Wenzhou, Zhejiang, China

Beijing Anzhen Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

The First Affiliated Hospital of Henan University of Science and Technology

🇨🇳

Luoyang, Henan, China

The First Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

Zhongda Hospital Southeast Universty

🇨🇳

Nanjing, Jiangsu, China

Shanxi Provincial People's Hospital

🇨🇳

Taiyuan, Shanxi, China

Huashan Hospital Affiliated to Fudan University

🇨🇳

Shanghai, Shanghai, China

Qilu Hospital of Shandong University

🇨🇳

Jinan, Shandong, China

First Hospital of Shanxi Medical University

🇨🇳

Taiyuan, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath